Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
about
A phase II study of pemetrexed plus carboplatin followed by maintenance pemetrexed as first-line chemotherapy for elderly patients with advanced non-squamous non-small cell lung cancer.Participation of older newly-diagnosed cancer patients in an observational prospective pilot study: an example of recruitment and retentionIncreasing access to medical oncology consultation in older patients with stage II-IIIA non-small-cell lung cancerAdverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancerA systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment.Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study.The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer.Characteristics of randomized controlled trials designed for elderly: a systematic review.Therapeutic options in older patients with metastatic non-small cell lung cancer.A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial resultsExternal validity of randomized controlled trials in older adults, a systematic review.The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samplesSingle-institution experience of adjuvant 5-fluorouracil-based chemotherapy for stage III colon cancer.Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer.Non-small cell lung cancer in the elderly: defining treatment options.Impact of age on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancerOptimal pharmacotherapeutic strategies for elderly patients with advanced non-small cell lung cancer.Pharmacotherapy for treatment of lung cancer in the elderly.Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer.Weekly carboplatin in combination with weekly paclitaxel in the treatment of metastatic non-small cell lung cancer: a single center 10-year experience.Age-related systemic treatment and survival of patients with metachronous metastases from colorectal cancer.Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung CancerA phase II study of carboplatin plus weekly paclitaxel with bevacizumab for elderly patients with non-squamous non-small-cell lung cancer (NEJ016).The rapidly escalating cost of treating colorectal cancer in Australia.Combination therapy for older men with colorectal cancer: are two drugs better than one?Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer.Pathways and cost-effectiveness of routine lung cancer inpatient care in rural Anhui, China: a retrospective cohort study protocol.Management of elderly patients with NSCLC; updated expert's opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology.Developing a national database for metastatic colorectal cancer management: perspectives and challenges.Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
P2860
Q33427832-5A4D09AA-4299-4BFC-9181-9F69E27026DCQ33491875-C7928574-EE2B-4BF9-9F2D-4C5896F65CD9Q33554024-A0B036C0-7AF8-4F12-815C-D2E9934DB4E5Q33628784-F3E652F1-0B41-454B-AD20-CF9E84F50DACQ34220474-8F680F6B-78C3-4334-A278-BFA453575541Q34730649-DBDF7FDC-C60A-4BB2-B02A-FA0DD7588337Q35201907-23F25DA9-7AB3-41C3-BF86-02384CBB6847Q35610529-B6F27A40-956F-4114-8CBB-17D5CCDC437FQ36180083-75DEC0FF-EFEF-4CE6-97C7-F9BA5C3D9581Q36246590-BCF1275D-AC1B-4302-ACFC-A7598491B8F1Q36323889-3CF5FE62-5488-4E07-9D12-F2B2F80AE1A1Q36496681-6AB30103-C983-4D05-857D-437CAA88AD34Q37093977-01C065D7-8795-4869-AB48-D1E3CB771434Q37109941-215B81EF-2714-47FB-82DC-1EFB370A9091Q37113563-4556AE02-AD79-4EEC-81CB-7923388FB22FQ37240128-D4C3D652-CA04-4C93-8F17-7E156E242AD3Q37321102-3636CF7D-C03F-40A2-9A37-E184EA047C9DQ37952852-6AD96DAD-40BC-4C81-8E62-83A5B8BB4CE2Q38386745-FA2EEF31-21D1-4B24-ACF2-54B8A49701ABQ38518602-F767B242-C180-4AFE-B759-1362FDB69BFAQ38629219-D619A915-ACE7-4009-A43A-44415D5D4ABAQ38825369-B8124BBC-3F2E-4400-B349-842E2B7CBE72Q38938753-FCF27623-5D24-4F8E-B148-2AE2B5A6A987Q40349242-C37205CE-342C-4EB6-9355-3E8BFA4C9B10Q41083423-2E0BD347-BD84-466A-A865-E81BE8BCB9D7Q45378019-51897E0C-13B9-476B-993E-B48A7F1F27C1Q47096908-23A22846-89F0-4768-8484-F150FF902262Q49791598-D27A231F-2240-4F99-9831-4819C9025C51Q53061916-7E3B3E5E-D169-4D2E-9827-C549C653D50AQ53107300-9C501572-3F65-403B-81AB-B243E361EE7CQ54422507-3DB75D43-916B-49B1-9F69-438BDE028CE6
P2860
Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Increasing underrepresentation ...... cancer in chemotherapy trials.
@ast
Increasing underrepresentation ...... cancer in chemotherapy trials.
@en
type
label
Increasing underrepresentation ...... cancer in chemotherapy trials.
@ast
Increasing underrepresentation ...... cancer in chemotherapy trials.
@en
prefLabel
Increasing underrepresentation ...... cancer in chemotherapy trials.
@ast
Increasing underrepresentation ...... cancer in chemotherapy trials.
@en
P2860
P1476
Increasing underrepresentation ...... cancer in chemotherapy trials.
@en
P2093
P2860
P304
P356
10.1111/J.1445-5994.2006.01033.X
P577
2006-04-01T00:00:00Z